Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2012, Article ID 170172, 12 pages
http://dx.doi.org/10.1155/2012/170172
Review Article

Methylation-Mediated Molecular Dysregulation in Clinical Oral Malignancy

1Department of Integrative Oncology, British Columbia Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, Canada V5Z 1L3
2Division of Otolaryngology, Department of Surgery, Faculty of Medicine, University of British Columbia, 910 West 10th Avenue, Vancouver, BC, Canada V5Z 4E3

Received 24 December 2011; Revised 18 February 2012; Accepted 19 February 2012

Academic Editor: Frederick E. Domann

Copyright © 2012 Rebecca Towle and Cathie Garnis. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Takai and P. A. Jones, “Comprehensive analysis of CpG islands in human chromosomes 21 and 22,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 6, pp. 3740–3745, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. R. S. Illingworth and A. P. Bird, “CpG islands—“a rough guide”,” FEBS Letters, vol. 583, no. 11, pp. 1713–1720, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Bird, “DNA methylation patterns and epigenetic memory,” Genes and Development, vol. 16, no. 1, pp. 6–21, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. A. G. Knudson Jr., “Mutation and cancer: statistical study of retinoblastoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 68, no. 4, pp. 820–823, 1971. View at Google Scholar · View at Scopus
  6. C. A. Eads, K. D. Danenberg, K. Kawakami et al., “MethyLight: a high-throughput assay to measure DNA methylation,” Nucleic Acids Research, vol. 28, no. 8, p. E32, 2000. View at Google Scholar · View at Scopus
  7. Z. Xiong and P. W. Laird, “COBRA: a sensitive and quantitative DNA methylation assay,” Nucleic Acids Research, vol. 25, no. 12, pp. 2532–2534, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Tost and I. G. Gut, “DNA methylation analysis by pyrosequencing,” Nature Protocols, vol. 2, no. 9, pp. 2265–2275, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Bibikova and J.-B. Fan, “Genome-wide DNA methylation profiling,” Wiley Interdisciplinary Reviews: Systems Biology and Medicine, vol. 2, no. 2, pp. 210–223, 2010. View at Publisher · View at Google Scholar
  10. T. H. M. Huang, M. R. Perry, and D. E. Laux, “Methylation profiling of CpG islands in human breast cancer cells,” Human Molecular Genetics, vol. 8, no. 3, pp. 459–470, 1999. View at Google Scholar · View at Scopus
  11. M. Weber, J. J. Davies, D. Wittig et al., “Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells,” Nature Genetics, vol. 37, no. 8, pp. 853–862, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Wu, L. T. Smith, C. Plass, and T. H. M. Huang, “ChIP-chip comes of age for genome-wide functional analysis,” Cancer Research, vol. 66, no. 14, pp. 6899–6902, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. P. J. Park, “ChIP-seq: advantages and challenges of a maturing technology,” Nature Reviews Genetics, vol. 10, no. 10, pp. 669–680, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Bibikova, J. Le, B. Barnes et al., “Genome-wide DNA methylation profiling using Infinium assay,” Epigenomics, vol. 1, no. 1, pp. 177–200, 2009. View at Google Scholar
  15. M. Frommer, L. E. McDonald, D. S. Millar et al., “A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 5, pp. 1827–1831, 1992. View at Google Scholar · View at Scopus
  16. M. Ehrich, S. Zoll, S. Sur, and D. van den Boom, “A new method for accurate assessment of DNA quality after bisulfite treatment,” Nucleic Acids Research, vol. 35, no. 5, article e29, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. D. D. Silva, A. Ferlito, R. P. Takes et al., “Advances and applications of oral cancer basic research,” Oral Oncology, vol. 47, no. 9, pp. 783–791, 2011. View at Publisher · View at Google Scholar
  18. R. K. Lin, Y. S. Hsieh, P. Lin et al., “The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients,” Journal of Clinical Investigation, vol. 120, no. 2, pp. 521–532, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. Belinsky, D. M. Klinge, C. A. Stidley et al., “Inhibition of DNA Methylation and Histone Deacetylation Prevents Murine Lung Cancer,” Cancer Research, vol. 63, no. 21, pp. 7089–7093, 2003. View at Google Scholar · View at Scopus
  20. V. Papadimitrakopoulou, J. Izzo, S. M. Lippman et al., “Frequent inactivation of p16(INK4α) in oral premalignant lesions,” Oncogene, vol. 14, no. 15, pp. 1799–1803, 1997. View at Google Scholar · View at Scopus
  21. Y. Nakahara, S. Shintani, M. Mihara, Y. Ueyama, and T. Matsumura, “High frequency of homozygous deletion and methylation of p16INK4A gene in oral squamous cell carcinomas,” Cancer Letters, vol. 163, no. 2, pp. 221–228, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Akanuma, N. Uzawa, M. A. Yoshida, A. Negishi, T. Amagasa, and T. Ikeuchi, “Inactivation patterns of the p16 (INK4a) gene in oral squamous cell carcinoma cell lines,” Oral Oncology, vol. 35, no. 5, pp. 476–483, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. D. T. Cody II, Y. Huang, C. J. Darby, G. K. Johnson, and F. E. Domann, “Differential DNA methylation of the p16 INK4A/CDKN2A promoter in human oral cancer cells and normal human oral keratinocytes,” Oral Oncology, vol. 35, no. 5, pp. 516–522, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Viswanathan, N. Tsuchida, and G. Shanmugam, “Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma,” International Journal of Cancer, vol. 105, no. 1, pp. 41–46, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. R. J. Shaw, T. Liloglou, S. N. Rogers et al., “Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing,” British Journal of Cancer, vol. 94, no. 4, pp. 561–568, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. J. K. Lee, M. J. Kim, S. P. Hong, and S. D. Hong, “Inactivation patterns of p16/INK4A in oral squamous cell carcinomas,” Experimental and Molecular Medicine, vol. 36, no. 2, pp. 165–171, 2004. View at Google Scholar · View at Scopus
  27. T. N. Tran, Y. Liu, M. Takagi, A. Yamaguchi, and H. Fujii, “Frequent promoter hypermethylation of RASSF1A and p16INK4a and infrequent allelic loss other than 9p21 in betel-associated oral carcinoma in a Vietnamese non-smoking/non-drinking female population,” Journal of Oral Pathology and Medicine, vol. 34, no. 3, pp. 150–156, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. P. F. Su, W. L. Huang, H. T. Wu, C. H. Wu, T. Y. Liu, and S. Y. Kao, “P16INK4A promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner,” Oral Oncology, vol. 46, no. 10, pp. 734–739, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Sailasree, A. Abhilash, K. M. Sathyan, K. R. Nalinakumari, S. Thomas, and S. Kannan, “Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma,” Cancer Epidemiology, Biomarkers & Prevention, vol. 17, no. 2, pp. 414–420, 2008. View at Google Scholar
  30. E. Ishida, M. Nakamura, M. Ikuta et al., “Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma,” Oral Oncology, vol. 41, no. 6, pp. 614–622, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Ogi, M. Toyota, M. Ohe-Toyota et al., “Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma,” Clinical Cancer Research, vol. 8, no. 10, pp. 3164–3171, 2002. View at Google Scholar · View at Scopus
  32. P. Sinha, S. Bahadur, A. Thakar et al., “Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue,” Head & Neck, vol. 31, no. 11, pp. 1423–1430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Kato, A. Hara, T. Kuno et al., “Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa,” Journal of Cancer Research and Clinical Oncology, vol. 132, no. 11, pp. 735–743, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Šupić, R. Kozomara, M. Branković-Magić, N. Jović, and Z. Magić, “Gene hypermethylation in tumor tissue of advanced oral squamous cell carcinoma patients,” Oral Oncology, vol. 45, no. 12, pp. 1051–1057, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Berx and F. van Roy, “Involvement of members of the cadherin superfamily in cancer,” Cold Spring Harbor Perspectives in Biology, vol. 1, no. 6, p. a003129, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. H. W. Chang, V. Chow, K. Y. Lam, W. I. Wei, and A. P. WingYuen, “Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance,” Cancer, vol. 94, no. 2, pp. 386–392, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Esteller, “Aberrant DNA methylation as a cancer-inducing mechanism,” Annual Review of Pharmacology and Toxicology, vol. 45, pp. 629–656, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. S. L. B. Rosas, W. Koch, M. D. G. Da Costa Carvalho et al., “Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of Head & Neck cancer patients,” Cancer Research, vol. 61, no. 3, pp. 939–942, 2001. View at Google Scholar · View at Scopus
  39. V. Kulkarni and D. Saranath, “Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues,” Oral Oncology, vol. 40, no. 2, pp. 145–153, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. S.-H. Huang, H.-S. Lee, K. Mar, D.-D. Ji, M.-S. Huang, and K.-T. Hsia, “Loss expression of O6-methylguanine DNA methyltransferase by promoter hypermethylation and its relationship to betel quid chewing in oral squamous cell carcinoma,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 109, no. 6, pp. 883–889, 2010. View at Publisher · View at Google Scholar
  41. C. Zuo, L. Ai, P. Ratliff et al., “O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in Head & Neck squamous cell carcinoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 6, pp. 967–975, 2004. View at Google Scholar · View at Scopus
  42. J. Paluszczak, P. Misiak, M. Wierzbicka, A. Woźniak, and W. Baer-Dubowska, “Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa,” Oral Oncology, vol. 47, no. 2, pp. 104–107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Sawhney, N. Rohatgi, J. Kaur et al., “MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis,” Oral Oncology, vol. 43, no. 5, pp. 515–522, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Jiang, Z.-P. Wei, D.-S. Pei, Y. Xin, Y.-Q. Liu, and J.-N. Zheng, “A novel approach to overcome temozolomide resistance in glioma and melanoma: inactivation of MGMT by gene therapy,” Biochemical and Biophysical Research Communications, vol. 406, no. 3, pp. 311–314, 2011. View at Publisher · View at Google Scholar
  45. S. Sharma, F. Salehi, B. W. Scheithauer, F. Rotondo, L. V. Syro, and K. Kovacs, “Role of MGMT in tumor development, progression, diagnosis, treatment and prognosis,” Anticancer Research, vol. 29, no. 10, pp. 3759–3768, 2009. View at Google Scholar · View at Scopus
  46. M. Airoldi, G. Cortesina, C. Giordano, F. Pedani, and C. Bumma, “Ifosfamide in the treatment of Head & Neck cancer,” Oncology, vol. 65, supplement 2, no. 2, pp. 37–43, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. M. S. Kies, D. H. Boatright, G. Li et al., “Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults,” Head & Neck. In press. View at Publisher · View at Google Scholar
  48. A. M. Michie, A. M. McCaig, R. Nakagawa, and M. Vukovic, “Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer,” FEBS Journal, vol. 277, no. 1, pp. 74–80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Sanchez-Cespedes, M. Esteller, L. Wu et al., “Gene promoter hypermethylation in tumors and serum of Head & Neck cancer patients,” Cancer Research, vol. 60, no. 4, pp. 892–895, 2000. View at Google Scholar · View at Scopus
  50. W. J. Kong, S. Zhang, C. Guo, S. Zhang, Y. Wang, and D. Zhang, “Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer,” Laryngoscope, vol. 115, no. 8, pp. 1395–1401, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. R. P. Dikshit, A. Gillio-Tos, P. Brennan et al., “Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers,” Cancer, vol. 110, no. 8, pp. 1745–1751, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Supic, R. Kozomara, N. Jovic, K. Zeljic, and Z. Magic, “Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas,” Oral Oncology, vol. 47, no. 8, pp. 702–708, 2011. View at Publisher · View at Google Scholar
  53. Y. Kudo, T. Tsunematsu, and T. Takata, “Oncogenic role of RUNX3 in Head & Neck cancer,” Journal of Cellular Biochemistry, vol. 112, no. 2, pp. 387–393, 2011. View at Publisher · View at Google Scholar
  54. F. Gao, C. Huang, M. Lin et al., “Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas,” Journal of Cancer Research and Clinical Oncology, vol. 135, no. 5, pp. 739–747, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Reya and H. Clevers, “Wnt signalling in stem cells and cancer,” Nature, vol. 434, no. 7035, pp. 843–850, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. N. Barker and H. Clevers, “Mining the Wnt pathway for cancer therapeutics,” Nature Reviews Drug Discovery, vol. 5, no. 12, pp. 997–1014, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Fodde and T. Brabletz, “Wnt/β-catenin signaling in cancer stemness and malignant behavior,” Current Opinion in Cell Biology, vol. 19, no. 2, pp. 150–158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. A. A. Molinolo, P. Amornphimoltham, C. H. Squarize, R. M. Castilho, V. Patel, and J. S. Gutkind, “Dysregulated molecular networks in Head & Neck carcinogenesis,” Oral Oncology, vol. 45, no. 4-5, pp. 324–334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. C. J. Marsit, M. D. McClean, C. S. Furniss, and K. T. Kelsey, “Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in Head & Neck squamous cell carcinoma,” International Journal of Cancer, vol. 119, no. 8, pp. 1761–1766, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Sogabe, H. Suzuki, M. Toyota et al., “Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma,” International Journal of Oncology, vol. 32, no. 6, pp. 1253–1261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. G. Pannone, P. Bufo, A. Santoro et al., “WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors,” Oncology Reports, vol. 24, no. 4, pp. 1035–1041, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. C. H. Lee, Y. J. Hung, C. Y. Lin, P. H. Hung, H. W. Hung, and Y. S. Shieh, “Loss of SFRP1 expression is associated with aberrant β-catenin distribution and tumor progression in mucoepidermoid carcinoma of salivary glands,” Annals of Surgical Oncology, vol. 17, no. 8, pp. 2237–2246, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Pérez-Sayáns, J. M. Suárez-Peñaranda, M. Herranz-Carnero et al., “The role of the adenomatous polyposis coli (APC) in oral squamous cell carcinoma,” Oral Oncology, vol. 48, no. 1, pp. 56–60, 2012. View at Publisher · View at Google Scholar
  64. H. Uesugi, K. Uzawa, K. Kawasaki et al., “Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma,” International Journal of Molecular Medicine, vol. 15, no. 4, pp. 597–602, 2005. View at Google Scholar · View at Scopus
  65. M. Fujii, N. Katase, M. Lefeuvre et al., “Dickkopf (Dkk)-3 and β-catenin expressions increased in the transition from normal oral mucosal to oral squamous cell carcinoma,” Journal of Molecular Histology, vol. 42, no. 6, pp. 499–504, 2011. View at Publisher · View at Google Scholar
  66. G. Ravindran and H. Devaraj, “Aberrant expression of β-catenin and its association with ΔNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma,” Clinical Oral Investigations. In press. View at Publisher · View at Google Scholar
  67. Y. Ying and Q. Tao, “Epigenetic disruption of the WNT/β-catenin signaling pathway in human cancers,” Epigenetics, vol. 4, no. 5, pp. 34–39, 2009. View at Google Scholar · View at Scopus
  68. P. Lopez-Serra and Esteller M., “DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer,” Oncogene, vol. 31, no. 13, pp. 1609–1622, 2012. View at Google Scholar
  69. A. Lujambio, A. Portela, J. Liz et al., “CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer,” Oncogene, vol. 29, no. 48, pp. 6390–6401, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. K. C. Miranda, T. Huynh, Y. Tay et al., “A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes,” Cell, vol. 126, no. 6, pp. 1203–1217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Iwama, T. Masaki, and S. Kuriyama, “Abundance of microRNA target motifs in the 3′-UTRs of 20 527 human genes,” FEBS Letters, vol. 581, no. 9, pp. 1805–1810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. A. M. Duursma, M. Kedde, M. Schrier, C. Le Sage, and R. Agami, “miR-148 targets human DNMT3b protein coding region,” RNA, vol. 14, no. 5, pp. 872–877, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Esquela-Kerscher and F. J. Slack, “Oncomirs—microRNAs with a role in cancer,” Nature Reviews Cancer, vol. 6, no. 4, pp. 259–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. S. M. Hammond, “MicroRNAs as tumor suppressors,” Nature Genetics, vol. 39, no. 5, pp. 582–583, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. A. Lujambio and M. Esteller, “How epigenetics can explain human metastasis: a new role for microRNAs,” Cell Cycle, vol. 8, no. 3, pp. 377–382, 2009. View at Google Scholar · View at Scopus
  76. A. Uesugi, K.-I. Kozaki, T. Tsuruta et al., “The tumor suppressive microRNA miR-218 targets the mTOR component rictor and inhibits AKT phosphorylation in oral cancer,” Cancer Research, vol. 71, no. 17, pp. 5765–5778, 2011. View at Publisher · View at Google Scholar
  77. J. Zheng, H. Xue, T. Wang et al., “miR-21 downregulates the tumor suppressor P12 CDK2AP1and stimulates cell proliferation and invasion,” Journal of Cellular Biochemistry, vol. 112, no. 3, pp. 872–880, 2011. View at Publisher · View at Google Scholar
  78. Y. Saito, G. Liang, G. Egger et al., “Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells,” Cancer Cell, vol. 9, no. 6, pp. 435–443, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. L. Han, P. D. Witmer, E. Casey, D. Valle, and S. Sukumar, “DNA methylation regulates microRNA expression,” Cancer Biology and Therapy, vol. 6, no. 8, pp. 1284–1288, 2007. View at Google Scholar · View at Scopus
  80. A. Lujambio, S. Ropero, E. Ballestar et al., “Genetic unmasking of an epigenetically silenced microRNA in human cancer cells,” Cancer Research, vol. 67, no. 4, pp. 1424–1429, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Toyota, H. Suzuki, Y. Sasaki et al., “Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer,” Cancer Research, vol. 68, no. 11, pp. 4123–4132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Lujambio, G. A. Calin, A. Villanueva et al., “A microRNA DNA methylation signature for human cancer metastasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 36, pp. 13556–13561, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. S. M. Langevin, R. A. Stone, C. H. Bunker et al., “MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck,” Cancer, vol. 117, no. 7, pp. 1454–1462, 2011. View at Google Scholar
  84. K. I. Kozaki, I. Imoto, S. Mogi, K. Omura, and J. Inazawa, “Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer,” Cancer Research, vol. 68, no. 7, pp. 2094–2105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. E. D. Wiklund, S. Gao, T. Hulf et al., “MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma,” PLoS ONE, vol. 6, no. 11, Article ID e27840, 2011. View at Publisher · View at Google Scholar
  86. F. Zhi, X. Chen, S. Wang et al., “The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma,” European Journal of Cancer, vol. 46, no. 9, pp. 1640–1649, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. J. Silber, D. A. Lim, C. Petritsch et al., “miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells,” BMC Medicine, vol. 6, article 14, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. L. T. Bemis, R. Chen, C. M. Amato et al., “MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines,” Cancer Research, vol. 68, no. 5, pp. 1362–1368, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. M. P. Rosin, W. L. Lam, C. Poh et al., “3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites,” Cancer Research, vol. 62, no. 22, pp. 6447–6450, 2002. View at Google Scholar · View at Scopus
  90. L. Mao, J. S. Lee, Y. H. Fan et al., “Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment,” Nature Medicine, vol. 2, no. 6, pp. 682–685, 1996. View at Publisher · View at Google Scholar · View at Scopus
  91. L. A. Kresty, S. R. Mallery, T. J. Knobloch et al., “Alterations of p16INK4a and p14ARF in patients with severe oral epithelial dysplasia,” Cancer Research, vol. 62, no. 18, pp. 5295–5300, 2002. View at Google Scholar · View at Scopus
  92. J. Cao, J. Zhou, Y. Gao et al., “Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study,” Clinical Cancer Research, vol. 15, no. 16, pp. 5178–5183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. M. Takeshima, M. Saitoh, K. Kusano et al., “High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka,” Journal of Oral Pathology and Medicine, vol. 37, no. 8, pp. 475–479, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. G. L. Hall, R. J. Shaw, E. A. Field et al., “p16 promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 8, pp. 2174–2179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Gasco, A. K. Bell, V. Heath et al., “Epigenetic inactivation of 14-3-3 σ in oral carcinoma: association with p16INK4a silencing and human papillomavirus negativity,” Cancer Research, vol. 62, no. 7, pp. 2072–2076, 2002. View at Google Scholar · View at Scopus
  96. N. K. Long, K. Kato, T. Yamashita et al., “Hypermethylation of the RECK gene predicts poor prognosis in oral squamous cell carcinomas,” Oral Oncology, vol. 44, no. 11, pp. 1052–1058, 2008. View at Publisher · View at Google Scholar · View at Scopus
  97. M. Toyota, N. Ahuja, M. Ohe-Toyota, J. G. Herman, S. B. Baylin, and J. P. J. Issa, “CpG island methylator phenotype in colorectal cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 15, pp. 8681–8686, 1999. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Toyota, N. Ahuja, H. Suzuki et al., “Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype,” Cancer Research, vol. 59, no. 21, pp. 5438–5442, 1999. View at Google Scholar · View at Scopus
  99. R. J. Shaw, G. L. Hall, D. Lowe et al., “CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology,” Oral Oncology, vol. 43, no. 9, pp. 878–886, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. C. J. Marsit, E. A. Houseman, B. C. Christensen et al., “Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors,” Cancer Research, vol. 66, no. 21, pp. 10621–10629, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. W. Sun, Y. Liu, C. A. Glazer et al., “TKTL1 is activated by promoter hypomethylation and contributes to Head & Neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1α stabilization,” Clinical Cancer Research, vol. 16, no. 3, pp. 857–866, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. Y. Yamada, L. Jackson-Grusby, H. Linhart et al., “Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 38, pp. 13580–13585, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. P. W. Laird, L. Jackson-Grusby, A. Fazeli et al., “Suppression of intestinal neoplasia by DNA hypomethylation,” Cell, vol. 81, no. 2, pp. 197–205, 1995. View at Google Scholar · View at Scopus
  104. J. A. Gasche, J. Hoffmann, C. R. Boland, and A. Goel, “Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells,” International Journal of Cancer, vol. 129, no. 5, pp. 1053–1063, 2011. View at Publisher · View at Google Scholar
  105. S. Baba, Y. Yamada, Y. Hatano et al., “Global DNA hypomethylation suppresses squamous carcinogenesis in the tongue and esophagus,” Cancer Science, vol. 100, no. 7, pp. 1186–1191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. K. Subbalekha, A. Pimkhaokham, P. Pavasant et al., “Detection of LINE-1s hypomethylation in oral rinses of oral squamous cell carcinoma patients,” Oral Oncology, vol. 45, no. 2, pp. 184–191, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. C. T. Viet and B. L. Schmidt, “Methylation array analysis of preoperative and postoperative saliva DNA in oral cancer patients,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 12, pp. 3603–3611, 2008. View at Publisher · View at Google Scholar
  108. C. A. Righini, F. De Fraipont, J. F. Timsit et al., “Tumor-specific methylation in saliva: a promising biomarker for early detection of Head & Neck cancer recurrence,” Clinical Cancer Research, vol. 13, no. 4, pp. 1179–1185, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. M. López, J. M. Aguirre, N. Cuevas et al., “Gene promoter hypermethylation in oral rinses of leukoplakia patients—a diagnostic and/or prognostic tool?” European Journal of Cancer, vol. 39, no. 16, pp. 2306–2309, 2003. View at Publisher · View at Google Scholar · View at Scopus
  110. M. Esteller, M. Sanchez-Cespedes, R. Resell, D. Sidransky, S. B. Baylin, and J. G. Herman, “Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients,” Cancer Research, vol. 59, no. 1, pp. 67–70, 1999. View at Google Scholar · View at Scopus
  111. I. H. N. Wong, Y. M. D. Lo, J. Zhang et al., “Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients,” Cancer Research, vol. 59, no. 1, pp. 71–73, 1999. View at Google Scholar · View at Scopus
  112. K. Hibi, C. R. Robinson, S. Booker et al., “Molecular detection of genetic alterations in the serum of colorectal cancer patients,” Cancer Research, vol. 58, no. 7, pp. 1405–1407, 1998. View at Google Scholar · View at Scopus
  113. A. L. Carvalho, C. Jeronimo, M. M. Kim et al., “Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for Head & Neck squamous cell carcinoma,” Clinical Cancer Research, vol. 14, no. 1, pp. 97–107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  114. Y. Nakahara, S. Shintani, M. Mihara, S. Hino, and H. Hamakawa, “Detection of p16 promoter methylation in the serum of oral cancer patients,” International Journal of Oral and Maxillofacial Surgery, vol. 35, no. 4, pp. 362–365, 2006. View at Publisher · View at Google Scholar · View at Scopus
  115. K. Hibi, M. Taguchi, H. Nakayama et al., “Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma,” Clinical Cancer Research, vol. 7, no. 10, pp. 3135–3138, 2001. View at Google Scholar · View at Scopus